Study Reveals Potential Risks of Glucosamine for Alzheimer's Patients

Want the full story?
Read the complete article at KTSM
AI Summary
A recent study has raised concerns about glucosamine supplements, commonly taken by over 40 million Americans annually, suggesting they may accelerate memory loss in individuals with Alzheimer's disease. This finding is significant as glucosamine is often used for joint health, but its implications on cognitive function warrant further investigation. The research highlights the need for caution among those considering glucosamine, particularly for older adults or those with existing cognitive impairments. Residents are advised to consult healthcare professionals before starting any new supplement regimen.
Key Details: • Over 40 million Americans use glucosamine supplements each year. • The study indicates a possible link between glucosamine and accelerated memory loss in Alzheimer's patients. • Healthcare professionals should be consulted before starting glucosamine, especially for older adults.